WFG Scleral Lenses for Keratoconus
Phase-Based Progress Estimates
Effectiveness
Safety
Keratoconus+7 More
Wavefront Guided Scleral Lenses - DeviceEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial is testing a new type of contact lens that may help improve vision for people with certain eye conditions.
Eligible Conditions
- Keratoconus
- Cornea
- Pellucid Marginal Corneal Degeneration
- Wavefront Aberration, Corneal
- Irregular Astigmatism
- Keratoglobus
Treatment Effectiveness
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: 4 weeks
4 weeks
Contrast Sensitivity
Higher order aberration
Visual Acuity
Trial Safety
Trial Design
2 Treatment Groups
WFG Scleral Lenses
1 of 2
Traditional Scleral Lenses
1 of 2
Active Control
Non-Treatment Group
100 Total Participants · 2 Treatment Groups
Primary Treatment: WFG Scleral Lenses · Has Placebo Group · N/A
Traditional Scleral Lenses
Device
PlaceboComparator Group · 1 Intervention: Traditional Scleral Lenses · Intervention Types: DeviceWFG Scleral Lenses
Device
ActiveComparator Group · 1 Intervention: Wavefront Guided Scleral Lenses · Intervention Types: DeviceTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 4 weeks
Who is running the clinical trial?
Cornea and Laser Eye InstituteLead Sponsor
9 Previous Clinical Trials
1,013 Total Patients Enrolled
9 Trials studying Keratoconus
1,013 Patients Enrolled for Keratoconus
John D Gelles, ODPrincipal InvestigatorThe Cornea and Laser Eye Institute
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments